Doctor Nicholas Jones
University of Oxford, Oxford (United Kingdom of Great Britain & Northern Ireland)
Low dose spironolactone and cardiovascular outcomes in moderate stage chronic kidney disease: the BARACK-D randomised trial
Event: ESC Congress 2024
Topic: e-Cardiology/Digital Health
Session: Nature Medicine: 2024 highlights in personalised cardiovascular medicine
Body mass index and survival in people with heart failure
Event: ESC Congress 2022
Topic: Epidemiology, Prognosis, Outcome
Session: Chronic heart failure - Epidemiology, prognosis, outcome 2
Survival among people with heart failure and atrial fibrillation; a population cohort study
Event: ESC Congress 2022
Topic: Epidemiology, Prognosis, Outcome
Session: Chronic heart failure and atrial fibrillation
